Walking for Stress Reduction

This study has been completed.
Information provided by (Responsible Party):
Benno Brinkhaus, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
First received: October 24, 2012
Last updated: October 29, 2012
Last verified: October 2012

The effectiveness of a mindfulness walking program is tested in subjects with a high level of subjectively perceived stress.

Condition Intervention
Healthy Subjects.
Behavioral: Mindfulness Walking

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effectiveness of Mindfulness Walking on Stress Reduction

Further study details as provided by Charite University, Berlin, Germany:

Primary Outcome Measures:
  • Cohens Perceived Stress Scale 14 Items [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Quality of Life (SF 36) [ Time Frame: Baseline, 4 weeks, 12 weeks ] [ Designated as safety issue: No ]
  • Subjective Stress Level (Visual Analogue Scale) [ Time Frame: Baseline, 4 weeks, 12 weeks ] [ Designated as safety issue: No ]
  • Assessment of effect on a Likert - Scale [ Time Frame: 4 weeks, 12 weeks ] [ Designated as safety issue: No ]

Enrollment: 74
Study Start Date: March 2011
Study Completion Date: November 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Mindfulness walking Behavioral: Mindfulness Walking
Mindful walking in a small group twice a week for 60 minutes within 4 weeks.
No Intervention: No intervention (waiting list)


Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy men and women between 18 and 65 years
  • Increased level of stress (visual analog scale >40 mm (0-100))

Exclusion Criteria:

  • Regular walking training in the last 6 weeks
  • Medical therapy with psychopharmacological drugs
  • Regular mindfulness based meditations/exercises in the last 6 weeks
  • CAM therapies against stress in the last 6 weeks
  • medium or severe chronic diseases
  • Stress due to chronic diseases
  • Acute disease at inclusion
  • Not being able to walk
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01716832

Charité University Berlin
Berlin, Germany, 10117
Sponsors and Collaborators
Charite University, Berlin, Germany
  More Information

No publications provided

Responsible Party: Benno Brinkhaus, Prof. MD, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT01716832     History of Changes
Other Study ID Numbers: Walking_Stress_Reduction
Study First Received: October 24, 2012
Last Updated: October 29, 2012
Health Authority: Germany: Ethics Commission

ClinicalTrials.gov processed this record on April 14, 2014